In last trading session, Maravai LifeSciences Holdings Inc (NASDAQ:MRVI) saw 0.83 million shares changing hands with its beta currently measuring -0.05. Company’s recent per share price level of $5.66 trading at -$0.26 or -4.39% at ring of the bell on the day assigns it a market valuation of $1.43B. That closing price of MRVI’s stock is at a discount of -104.24% from its 52-week high price of $11.56 and is indicating a premium of 24.38% from its 52-week low price of $4.28. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 2.27 million shares which gives us an average trading volume of 1.84 million if we extend that period to 3-months.
For Maravai LifeSciences Holdings Inc (MRVI), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.93. Splitting up the data highlights that, out of 7 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 1 suggested the stock as a Hold whereas 6 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.04 in the current quarter.
Maravai LifeSciences Holdings Inc (NASDAQ:MRVI) trade information
Upright in the red during last session for losing -4.39%, in the last five days MRVI remained trading in the green while hitting it’s week-highest on Wednesday, 11/27/24 when the stock touched $5.66 price level, adding 5.82% to its value on the day. Maravai LifeSciences Holdings Inc’s shares saw a change of -13.59% in year-to-date performance and have moved 14.11% in past 5-day. Maravai LifeSciences Holdings Inc (NASDAQ:MRVI) showed a performance of -25.82% in past 30-days. Number of shares sold short was 6.96 million shares which calculate 3.1 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 22 to the stock, which implies a rise of 74.27% to its current value. Analysts have been projecting 10 as a low price target for the stock while placing it at a high target of 25. It follows that stock’s current price would drop -76.68% in reaching the projected high whereas dropping to the targeted low would mean a loss of -76.68% for stock’s current value.
Maravai LifeSciences Holdings Inc (MRVI) estimates and forecasts
Statistics highlight that Maravai LifeSciences Holdings Inc is scoring comparatively lower than the scores of other players of the relevant industry. The company lost -34.72% of value to its shares in past 6 months, showing an annual growth rate of -366.67% while that of industry is 11.50. Apart from that, the company came lowering its revenue forecast for fiscal year 2024. This year revenue growth is estimated to fall -9.83% from the last financial year’s standing.
13 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 56.64M for the same. And 10 analysts are in estimates of company making revenue of 64.82M in the next quarter. Company posted 74.14M and 64.18M of sales in current and next quarters respectively a year earlier.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -37.53% during past 5 years. In 2024, company’s earnings growth rate is likely to be around -370.82% while estimates for its earnings growth in next 5 years are of 2.77%.
Maravai LifeSciences Holdings Inc (NASDAQ:MRVI)’s Major holders
Insiders are in possession of 1.37% of company’s total shares while institution are holding 102.82 percent of that, with stock having share float percentage of 104.25%. Investors also watch the number of corporate investors in a company very closely, which is 102.82% institutions for Maravai LifeSciences Holdings Inc that are currently holding shares of the company. GTCR LLC is the top institutional holder at MRVI for having 20.15 million shares of worth $144.27 million. And as of 2024-06-30, it was holding 15.2267 of the company’s outstanding shares.
The second largest institutional holder is 12 WEST CAPITAL MANAGEMENT LP, which was holding about 13.21 million shares on 2024-06-30. The number of shares represents firm’s hold over 9.9833 of outstanding shares, having a total worth of $94.59 million.
On the other hand, Vanguard Total Stock Market Index Fund and Vanguard Small-Cap Index Fund are the top two Mutual Funds which own company’s shares. As of Jun 30, 2024 , the former fund manager was holding 3.39 shares of worth $19.2 million or 2.39% of the total outstanding shares. The later fund manager was in possession of 3.02 shares on Sep 30, 2024 , making its stake of worth around $17.1 million in the company or a holder of 2.13% of company’s stock.
